Literature DB >> 21136999

Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicans.

Christopher F Hoehamer1, Edwin D Cummings, George M Hilliard, Joachim Morschhäuser, P David Rogers.   

Abstract

Azole resistance in Candida albicans is frequently caused by the overexpression of multi-drug efflux pump genes MDR1, CDR1, and CDR2 due to gain-of-function mutations in the zinc cluster transcription factors Mrr1p and Tac1p. In this study, we performed a comparative proteomic analysis to identify proteins whose expression level is influenced by these transcription factors. Both 2-DE and PMF were used to examine the expression profiles of six pairs of matched C. albicans isolates carrying gain-of-function mutations in either MRR1 or TAC1 resulting in the overexpression of either MDR1 or CDR1 and CDR2. Using this approach, 17 differentially expressed proteins were identified in the MDR1-overexpressing isolates, while 14 were identified in the isolates that overexpress CDR1 and CDR2. Furthermore, we found that the expression of many of these proteins was increased in a wild-type strain of C. albicans after the introduction of a gain-of-function allele of MRR1 or TAC1. Moreover, disruption of MRR1 and TAC1 in isolates carrying gain-of-function mutations resulted in decreased expression of these proteins, confirming their regulation by Mrr1p or Tac1p. Several proteins involved in heat shock and carbohydrate metabolism were differentially expressed in all clinical isolate sets, but these proteins were not dependent upon either Tac1p or Mrr1p.
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2009        PMID: 21136999      PMCID: PMC4694560          DOI: 10.1002/prca.200800252

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  44 in total

1.  Response of Saccharomyces cerevisiae to severe osmotic stress: evidence for a novel activation mechanism of the HOG MAP kinase pathway.

Authors:  O Van Wuytswinkel; V Reiser; M Siderius; M C Kelders; G Ammerer; H Ruis; W H Mager
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

2.  Proteomic analysis of azole resistance in Candida albicans clinical isolates.

Authors:  Massoumeh Z Hooshdaran; Katherine S Barker; George M Hilliard; Harald Kusch; Joachim Morschhäuser; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

3.  PDR16-mediated azole resistance in Candida albicans.

Authors:  Saloua Saidane; Sandra Weber; Xavier De Deken; Guy St-Germain; Martine Raymond
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 5.  Molecular genetic analysis of azole antifungal mode of action.

Authors:  S L Kelly; A Arnoldi; D E Kelly
Journal:  Biochem Soc Trans       Date:  1993-11       Impact factor: 5.407

6.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

7.  Associating protein activities with their genes: rapid identification of a gene encoding a methylglyoxal reductase in the yeast Saccharomyces cerevisiae.

Authors:  Ching-Nen Chen; Larysa Porubleva; Georgia Shearer; Maja Svrakic; Lauren G Holden; James L Dover; Mark Johnston; Parag R Chitnis; Daniel H Kohl
Journal:  Yeast       Date:  2003-04-30       Impact factor: 3.239

Review 8.  Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones.

Authors:  J H Doroshow; S Akman; F F Chu; S Esworthy
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

9.  Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Authors:  M Ruhnke; A Eigler; I Tennagen; B Geiseler; E Engelmann; M Trautmann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Genome-wide expression and location analyses of the Candida albicans Tac1p regulon.

Authors:  Teresa T Liu; Sadri Znaidi; Katherine S Barker; Lijing Xu; Ramin Homayouni; Saloua Saidane; Joachim Morschhäuser; André Nantel; Martine Raymond; P David Rogers
Journal:  Eukaryot Cell       Date:  2007-09-28
View more
  3 in total

1.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

2.  RNA sequencing revealed novel actors of the acquisition of drug resistance in Candida albicans.

Authors:  Sanjiveeni Dhamgaye; Maria Bernard; Gaelle Lelandais; Odile Sismeiro; Sophie Lemoine; Jean-Yves Coppée; Stéphane Le Crom; Rajendra Prasad; Frédéric Devaux
Journal:  BMC Genomics       Date:  2012-08-16       Impact factor: 3.969

3.  Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Authors:  Margot Delavy; Lorenzo Cerutti; Antony Croxatto; Guy Prod'hom; Dominique Sanglard; Gilbert Greub; Alix T Coste
Journal:  Front Microbiol       Date:  2020-01-14       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.